» Articles » PMID: 22314258

Occupational Causes of Sarcoidosis

Overview
Date 2012 Feb 9
PMID 22314258
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Sarcoidosis, the multiorgan granulomatous disease of unknown cause, remains mysterious. Several important investigations in the past 2 years add to the accumulating evidence for both occupational and environmental causes of granulomatous inflammation.

Recent Findings: This review considers the most recent studies that contribute to the hypothesis that sarcoidosis occurs when individuals are exposed to foreign antigens and to inorganic particulates that promote inflammation. Major recent findings, such as those emerging from the study of World Trade Center responders, the study of nanoparticles, and cases of work-associated sarcoidosis, support the probability that occupational, as well as environmental, exposures to inflammatory stimuli trigger sarcoidosis-like illness. Major recent studies of microbially rich indoor environments, including moldy indoor workplaces and mycobacterially contaminated settings, contribute to the evidence that a variety of microbial antigens serve as targets for the hypersensitivity immune response in an inflammatory milieu.

Summary: There is increasing evidence that sarcoidosis can occur in workplace settings in which there is exposure to both foreign antigens and inorganic triggers of inflammation that promote an exuberant granulomatous immune response. It is likely that sarcoidosis has more than one cause.

Citing Articles

Identification and validation of hub differential genes in pulmonary sarcoidosis.

Yao Q, Min K, Zhao M, Chen X, Weng D, Zhou Y Front Immunol. 2024; 15:1466029.

PMID: 39364409 PMC: 11446782. DOI: 10.3389/fimmu.2024.1466029.


A framework for exclusion of alternative diagnoses in sarcoidosis.

Harper L, Farver C, Yadav R, Culver D J Autoimmun. 2024; 149:103288.

PMID: 39084998 PMC: 11791745. DOI: 10.1016/j.jaut.2024.103288.


Cutaneous Sarcoidosis Induced by Laser Therapy: Case Report and Review of the Literature.

Cison H, Simon-Blazewicz M, Susel J, Susel M, Wozniak Z, Bialynicki-Birula R Life (Basel). 2024; 14(6).

PMID: 38929755 PMC: 11204518. DOI: 10.3390/life14060773.


History and Familial Aggregation of Immune-Mediated Diseases in Sarcoidosis: A Register-Based Case-Control-Family Study.

Rossides M, Kullberg S, Arkema E Chest. 2024; 166(5):1082-1092.

PMID: 38857779 PMC: 11562652. DOI: 10.1016/j.chest.2024.05.014.


Infectious and non-infectious precipitants of sarcoidosis.

Chioma O, Wiggins Z, Rea S, Drake W J Autoimmun. 2024; 149:103239.

PMID: 38821769 PMC: 11607178. DOI: 10.1016/j.jaut.2024.103239.


References
1.
Kawano-Dourado L, Carvalho C, Santos U, Canzian M, Coletta E, Pereira C . Tunnel excavation triggering pulmonary sarcoidosis. Am J Ind Med. 2011; 55(4):390-4. DOI: 10.1002/ajim.21030. View

2.
Bowers B, Hasni S, Gruber B . Sarcoidosis in World Trade Center rescue workers presenting with rheumatologic manifestations. J Clin Rheumatol. 2010; 16(1):26-7. DOI: 10.1097/RHU.0b013e3181c78856. View

3.
Tercelj M, Stopinsek S, Ihan A, Salobir B, Simcic S, Wraber B . In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis. Clin Exp Immunol. 2011; 166(1):87-93. PMC: 3193923. DOI: 10.1111/j.1365-2249.2011.04456.x. View

4.
Huizar I, Malur A, Midgette Y, Kukoly C, Chen P, Ke P . Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes. Am J Respir Cell Mol Biol. 2011; 45(4):858-66. PMC: 5460893. DOI: 10.1165/rcmb.2010-0401OC. View

5.
Billi F, Campbell P . Nanotoxicology of metal wear particles in total joint arthroplasty: a review of current concepts. J Appl Biomater Biomech. 2010; 8(1):1-6. View